Epigenetic Mechanisms in Breast Cancer Therapy and Resistance

Sanchita Bhatnagar

$418.95 $334.98

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer International Publishing AG
26 November 2024

Oncology; Medical microbiology & virology; Genetics (non-medical); DNA & Genome; Molecular biology

Series: Advances in Experimental Medicine and Biology

Epigenetic mechanisms are essential for normal mammalian development and maintenance of gene expression patterns. Disruption of epigenetic processes can lead to altered transcriptional regulation, gene levels, and malignant cellular transformation. Global alterations of the epigenetic landscape are a hallmark of tumorigenesis and metastasis. Conventionally, cancer was thought to be a genetic disease, but recent advancement in the field identified an abundance of epigenetic abnormalities along with genetic alterations. The extensive reprogramming of epigenetic machinery in cancer includes DNA methylation, histone modifications, nucleosome positioning and non-coding RNAs, specifically microRNA expression. Additionally, the reversible nature of epigenetic aberrations has led to the emergence of the promising field of epigenetic therapy, and recent FDA approval of epigenetic drugs for cancer treatment.

This book focuses on the epigenetic mechanisms in breast cancertherapy and resistance. It is organized into three sections, including epigenetic mechanisms in breast cancer, targeting epigenetic mechanisms for new therapies, and new and emerging methodologies to study epigenetic alterations in breast cancer. Chapters highlight various epigenetic regulations that prevent breast cancer growth and progression, as well as epigenetic alterations that contribute to breast cancer progression. This text is a useful methodology book for researchers and students interested in epigenetics in breast cancer and the fundamentals of cancer biology.

Edited by: Sanchita Bhatnagar
Imprint: Springer International Publishing AG
Country of Publication: Switzerland
Edition: 2025 ed.
Volume: 1465
Dimensions: Height: 254mm, Width: 178mm,
ISBN: 9783031666858
ISBN 10: 3031666852
Series: Advances in Experimental Medicine and Biology
Pages: 106
Publication Date: 26 November 2024
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Dr. Bhatnagar received her Ph.D. in Infectious diseases from the University of Notre Dame in 2007. She carried out her postdoctoral research with Dr. Michael R. Green at the University of Massachusetts Medical School in Worcester, MA. It was there that Dr. Bhatnagar began her work in understanding the epigenetic regulation of mammalian gene expression. Dr. Bhatnagar began her independent research career at the University of Virginia School of Medicine in 2015, where she was an Associate Professor in Biochemistry and Molecular Genetics. Recently, Dr. Bhatnagar joined the Medical Microbiology and Immunology department at University of California Davis. Dr. Bhatnagar’s research program focuses on (i) understanding epigenetic silencing mechanisms in the control of mammalian gene expression, (ii) investigate how these mechanisms are deployed during development, and (iii) identify critical steps that, when altered, disrupt normal function.